APC and infection: Therapeutic administration of recombinant murine APC (rmAPC) attenuated pulmonary coagulopathy and improved survival during infection with S. pneumoniae[19], whereas early administration of rmAPC also had anti-inflammatory effects as reflected by reduced levels of pro-inflammatory cytokines in lungs of rmAPC-treated mice [20].